Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00375011
What this trial is testing

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Who this might be right for
Cirrhosis
Meridian Bioscience, Inc. 200
Not applicableEnded earlyNCT00469963
What this trial is testing

Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Vanderbilt-Ingram Cancer Center 12
Very early researchUnknownNCT03099564
What this trial is testing

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects

Who this might be right for
Hepatocellular Carcinoma
Ashwin Somasundaram 30
Early research (Phase 1)WithdrawnNCT02288507
What this trial is testing

Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer

Who this might be right for
Hepatocellular Cancer
University of Hawaii
Not applicableLooking for participantsNCT07224464
What this trial is testing

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

Who this might be right for
Metastatic Solid TumorsStage 4 Cancer
New Phase Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT02449109
What this trial is testing

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma

Who this might be right for
Liver Cancer
Fuda Cancer Hospital, Guangzhou 60
Not applicableStudy completedNCT04177316
What this trial is testing

Hypermethylation of VTRNA2-1 Promoter in HCC Outcome

Who this might be right for
Hepatocellular Carcinoma Resectable
Chang Gung Memorial Hospital 92
Testing effectiveness (Phase 2)UnknownNCT02809534
What this trial is testing

Anlotinib in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Not applicableStudy completedNCT03428321
What this trial is testing

Small and Steatotic Hepatocellular Carcinoma

Who this might be right for
HCC
University Hospital, Montpellier 238
Not applicableActive Not RecruitingNCT05921552
What this trial is testing

Senior Adult Hepatobiliary Prehab Study

Who this might be right for
Hepatobiliary CancerCholangiocarcinomaLiver Metastases
H. Lee Moffitt Cancer Center and Research Institute 25
Large-scale testing (Phase 3)UnknownNCT01861912
What this trial is testing

Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Guangdong Provincial People's Hospital 258
Not applicableUnknownNCT05811481
What this trial is testing

Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChEmoembolizationRegorafenib
WenBo Guo 192
Testing effectiveness (Phase 2)Study completedNCT00052364
What this trial is testing

Oxaliplatin in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 32
Not applicableLooking for participantsNCT05466565
What this trial is testing

Antiviral Therapy for Patients With Liver Cancer After Surgery

Who this might be right for
Hepatocellular Carcinoma
Xiangya Hospital of Central South University 360
Testing effectiveness (Phase 2)Looking for participantsNCT04150744
What this trial is testing

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Who this might be right for
Tumor ImmunityImmunosuppressionRadiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05198609
What this trial is testing

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Not applicableUnknownNCT06070636
What this trial is testing

BTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Who this might be right for
Liver DiseasesHepatocellular CarcinomaImmunotherapy+2 more
Sun Yat-sen University 30
Not applicableApproved For MarketingNCT02436044
What this trial is testing

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Who this might be right for
Hepatocellular CarcinomaInjury; Blood Vessel, Hepatic, Artery
Ming Zhao
Not applicableUnknownNCT03739164
What this trial is testing

Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)

Who this might be right for
Liver CancerLiver TumorHepatocellular Carcinoma+1 more
Florida Hospital Tampa Bay Division 10
Next Page